IRM Cognition in Patients With Head Trauma

June 7, 2017 updated by: University Hospital, Clermont-Ferrand

Longitudinal Descriptive Study of the Correlation Between Cognitive Functions, White Matter Anatomical Pathways and Functional Magnetic Resonance Imaging Activations in Patients With Moderate to Severe Head Trauma.

Longitudinal descriptive study of a cohort of twenty brain-damaged patients for a two years period.

Study Overview

Status

Unknown

Detailed Description

The following data are collected in 3 months, 12 months then 24 months after the accident with followed data collection :

  • Clinical, neuropsychological assessments
  • Diffusion magnetic resonance imaging (MRI) for the reconstruction of anatomical pathways
  • Functional imaging data.

Study Type

Observational

Enrollment (Anticipated)

20

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Auvergne
      • Clermont-Ferrand, Auvergne, France, 63003
        • Chu Clermont-Ferrand

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Adult patients with traumatic brain injury

Description

Inclusion Criteria:

  • Adult patients, over the age of 18.
  • Mild traumatic brain injury (Initial Glasgow score between 9 and 12)
  • Severe brain injury (Initial Glasgow score between 3 and 8),
  • Diffuse axonal injury and/or focal lesions.

Exclusion Criteria:

  • Patients with MRI contraindications,
  • Antecedents of brain lesions,
  • Important lesions of the lobes and cortex on cerebral CT,
  • Anoxic lesions related to cardiorespiratory arrest,
  • Must be able to perform neuropsychological tests,
  • Visual and auditory impairments.
  • Aphasia

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Traumatic brain injury population
Defined population : traumatic brain injury population
Rehabilitation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in Baseline standardized volume of the white matter fascicles
Time Frame: at 3, 12 and 24 months
determined on the "iplan" software. Baseline measured at 3 months after brain traumatic injury.
at 3, 12 and 24 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Measure of the volume of activations clusters
Time Frame: at 3, 12 and 24 months
during functional MRI for attention, motor, working memory, language tasks.
at 3, 12 and 24 months
Location of activation clusters
Time Frame: at 3, 12 and 24 months
during functional MRI for attention, motor, working memory, language tasks.
at 3, 12 and 24 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 26, 2014

Primary Completion (Anticipated)

July 1, 2018

Study Completion (Anticipated)

December 1, 2018

Study Registration Dates

First Submitted

May 9, 2017

First Submitted That Met QC Criteria

June 7, 2017

First Posted (Actual)

June 8, 2017

Study Record Updates

Last Update Posted (Actual)

June 8, 2017

Last Update Submitted That Met QC Criteria

June 7, 2017

Last Verified

May 1, 2017

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Brain-damaged Patients

Clinical Trials on Cognitive rehabilitation program

3
Subscribe